戻る
Hansoh Pharmaceutical Group Company Limited (3692.HK)価格
3692.HK 株価推移チャート
HANSOH PHARMA (3692.HK)
Hansoh Pharmaceutical Group Company Limited
HK$43
-0.18%
$-0.07
休場: Jan 16, 16:00:00 HKT
A+
最終スコア
主要データ
前終値
$43.12
始値
$43.08
当日レンジ
$42.3 - $43.08
52週レンジ
$16.7 - $44.22
取引高
3.6M
平均取引高
8.3M
1株当たり利益(TTM)
0.89
配当利回り
--
時価総額
$255.6B
HANSOH PHARMAとは何ですか？
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,313 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.
